We just invested in Ynsect

Why we invested in Ynsect

Today, Ynsect, the first bio-refinery of insects in the world, announced its $15.3m series B, bringing the company’s total funding to $37.7mFuture Positive Capital (my new investment firm) co-led the round, alongside Bpifrance EcotechnologiesQuadia SA and the previous investors also chipped in, including EmertecDemeter and New Protein Capital.

Sofia joined the board as Director. Since this is our first public investment and given the growing interest in the alternative protein space, I wanted to take a moment to share why we invested.

Read More